Most cited papers from Clinique Hartmann

Clinique Hartmann

What are the most cited papers from Clinique Hartmann?

The most cited paper from Clinique Hartmann is "The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease" (Marcus Harbord et al., 2015), with 829 citations. Next come "Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study" (484) and "Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial" (379).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 43 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease Marcus Harbord et al. · Journal of Crohn s and Colitis Open access	27 Nov 2015	829
2	Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study Emmanuel Ekanem et al. · Nature Medicine Open access139 authors	Jul 2024	484
3	Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial Cornelis JH van de Velde, Daniel William Rea, Caroline Seynaeve et al. · The Lancet	2011	379
4	Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies William J. Sandborn, Severine A.R.A. Vermeire, Laurent Peyrin‐Biroulet et al. · The Lancet Open access	2 Mar 2023	363
5	Inflammation and malnutrition in inflammatory bowel disease Sara Massironi, Chiara Viganò, Andrea Palermo et al. · The Lancet. Gastroenterology & hepatology	15 Mar 2023	301
6	CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties Selim Kuçi, Zyrafete Kuçi, Hermann Kreyenberg et al. · Haematologica Open access	23 Feb 2010	195
7	Clinical practice guidelines for BRCA1 and BRCA2 genetic testing Pascal Pujol et al. · European Journal of Cancer Open access	10 Feb 2021	186
8	PROSPECT guideline for tonsillectomy: systematic review and procedure‐specific postoperative pain management recommendations Niamat Aldamluji, A. E. Burgess, Esther Miriam Pogatzki-Zahn et al. · Anaesthesia ReviewOpen access	17 Nov 2020	157
9	Agreement Between Clinical Practice and Trained Central Reading in Reading of Sacroiliac Joints on Plain Pelvic Radiographs: Results From the DESIR Cohort Rosaline van den Berg, G. Lenczner, A. Feydy et al. · Arthritis & Rheumatology	6 Jun 2014	156
10	Long-Term Results with the First Patellofemoral Prosthesis Philippe Cartier, Jean-Louis Sanouiller, Ahmed Khefacha · Clinical Orthopaedics and Related Research	Jul 2005	153
11	Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2 Stéphane Marie. Oudard et al. · European Journal of Cancer	17 Nov 2014	149
12	Use of [18F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [18F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial Bruno P. Coudert, Jean‐Yves Pierga, Marie‐Ange Mouret‐Reynier et al. · The Lancet Oncology	30 Oct 2014	148
13	A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma Francis L�vi, Rachid Zidani, Silvano Brienza et al. · Cancer Open access	15 Jun 1999	134
14	Structure of Advanced Planning Systems Herbert Meyr, Michael Wagner, Jens Rohde Book chapter	24 Oct 2007	125
15	Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial R. de Crevoisier, Mohamed Amine Bayar, Pascal Pommier et al. · International Journal of Radiation OncologyBiologyPhysics	30 Jul 2018	123
16	Effect of 18F-FDG PET/CT Imaging in Patients With Clinical Stage II and III Breast Cancer David Groheux, Jean‐Luc Moretti, Georges Y. Baillet et al. · International Journal of Radiation OncologyBiologyPhysics	24 Apr 2008	122
17	Survivorship of UKA in the middle-aged Thomas Jan Heyse, Ahmed Khefacha, Geert Peersman et al. · The Knee	2 Oct 2011	121
18	Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study Yazid Belkacémi, Joseph Gligorov, Mahmut Özsahin et al. · Annals of Oncology Open access	16 Mar 2008	119
19	Correlation and characterisation of individual glass shards from tephra deposits using trace element laser ablation ICP‐MS analyses: current status and future potential Nicholas J.G. Pearce, Joanna S. Denton, William T. Perkins et al. · Journal of Quaternary Science Open access	23 Apr 2007	112
20	Navigating the complexities of drug development for inflammatory bowel disease Sailish Honap, Vipul Jairath, Silvio Danese et al. · Nature Reviews Drug Discovery Review	22 May 2024	110
21	Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study Jean-Marc Extra, Éric Charles Antoine, Anne Vincent‐Salomon et al. · The Oncologist Open access	29 Jul 2010	110
22	Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU) Eric Van Cutsem, David Cunningham, Wim W. ten Bokkel Huinink et al. · European Journal of Cancer Open access	1999	109
23	Fixed- versus mobile-bearing UKA: a systematic review and meta-analysis Geert Peersman, Bart Stuyts, Tom Van den Langenbergh et al. · Knee Surgery Sports Traumatology Arthroscopy Review	23 Jun 2014	109
24	Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Gilles Manceau et al. · Clinical Cancer Research	25 Apr 2014	105
25	Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies David T. Rubin et al. · The Lancet Open access348 authors	17 Dec 2024	103
26	Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study Laurent Peyrin‐Biroulet et al. · Gastroenterology Open access164 authors	31 Aug 2023	102
27	Radiosurgery With or Without A 2-mm Margin for 93 Single Brain Metastases F. Nataf, Michel Schlienger, Zhihua Liu et al. · International Journal of Radiation OncologyBiologyPhysics	8 Feb 2008	97
28	Brachytherapy versus prostatectomy in localized prostate cancer: Results of a French multicenter prospective medico-economic study Catherine Buron, Béatrice Le Vu, Jean‐Marc Cosset et al. · International Journal of Radiation OncologyBiologyPhysics	10 Feb 2007	94
29	Management of cardiogenic shock: a narrative review Driss Laghlam, Sarah Benghanem, Sofia Ortuno et al. · Annals of Intensive Care ReviewOpen access	2024	93
30	Chronic Gingivo-Stomatitis in Cats: Long-Term follow-up of 30 cases Treated by Dental Extractions Philippe R. Hennet · Journal of Veterinary Dentistry	Mar 1997	90
31	Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUG David Pasquier, Geoffrey Martinage, Guillaume Janoray et al. · International Journal of Radiation OncologyBiologyPhysics Open access	22 Jul 2019	79
32	Classification of axial SpA based on positive imaging (radiographs and/or MRI of the sacroiliac joints) by local rheumatologists or radiologists versus central trained readers in the DESIR cohort Rosaline van den Berg, G. Lenczner, F. Thévenin et al. · Annals of the Rheumatic Diseases	25 Jun 2014	78
33	Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response Virginia Solitano, Charles Noah Bernstein, Iris Dotan et al. · Nature Reviews Gastroenterology & Hepatology ReviewOpen access	22 Apr 2025	75
34	Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations Pascal Pujol et al. · European Journal of Human Genetics Open access	8 Aug 2018	75
35	UKA after spontaneous osteonecrosis of the knee: a retrospective analysis Thomas Jan Heyse, Ahmed Khefacha, Susanne Fuchs‐Winkelmann et al. · Archives of Orthopaedic and Trauma Surgery	23 Aug 2010	75
36	Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy Aurélie Mbeutcha, L. Chauveinc, Pierre‐Yves Bondiau et al. · Radiation Oncology Open access	9 Mar 2017	72
37	Robotic surgery for inguinal and ventral hernia repair: a systematic review and meta-analysis Nicola de’Angelis, Carlo Alberto Schena, David Moszkowicz et al. · Surgical Endoscopy Review	20 Nov 2023	71
38	Air contamination for predicting wound contamination in clean surgery: A large multicenter study Gabriel Birgand, Gaëlle Toupet, Stephane Rukly et al. · American Journal of Infection Control	6 Mar 2015	69
39	Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus Barbara Alicja Jereczek‐Fossa et al. · Cancer Treatment Reviews Open access	20 Apr 2021	68
40	UKA in combination with PFR at average 12-year follow-up Thomas Jan Heyse, Ahmed Khefacha, Philippe Cartier · Archives of Orthopaedic and Trauma Surgery	3 Nov 2009	68
41	Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial William Jacot, Paul Henri Cottu, Frédérique Berger et al. · Breast Cancer Research Open access	14 Nov 2019	64
42	National Prevalence of Asthma and Chemical Hypersensitivity: An Examination of Potential Overlap Stanley M. Caress, Anne C. Steinemann · Journal of Occupational and Environmental Medicine	May 2005	62
43	Radiothérapie du cancer du sein Christophe Hennequin, I. Barillot, D. Azria et al. · Cancer/Radiothérapie	11 Aug 2016	60
44	Indocyanine green fluorescence angiography could reduce the risk of anastomotic leakage in rectal cancer surgery: a systematic review and meta‐analysis of randomized controlled trials Alessio Lucarini, Andrea Martina Guida, Marion Orville et al. · Colorectal Disease Review	21 Jan 2024	58
45	Cost-effectiveness of unicondylar versus total knee arthroplasty: a Markov model analysis Geert Peersman, Wouter Jak, Tom Van den Langenbergh et al. · The Knee	2014	58
46	Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study Bruce E. Sands, Geert D’Haens, David B. Clemow et al. · Inflammatory Bowel Diseases Open access	29 Jan 2024	55
47	Can we use structural lesions seen on MRI of the sacroiliac joints reliably for the classification of patients according to the ASAS axial spondyloarthritis criteria? Data from the DESIR cohort Pauline A. C. Bakker, Rosaline van den Berg, G. Lenczner et al. · Annals of the Rheumatic Diseases	5 Aug 2016	55
48	The yield of a positive MRI of the spine as imaging criterion in the ASAS classification criteria for axial spondyloarthritis: results from the SPACE and DESIR cohorts Z. Ez‐Zaitouni, Pauline A. C. Bakker, M. van Lunteren et al. · Annals of the Rheumatic Diseases	30 Jun 2017	54
49	Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy Raefa Abou Khouzam, Bassam Janji, Jérôme Thiery et al. · Seminars in Cancer Biology Open access	27 Nov 2023	49
50	Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis Sarah Bencardino, Ferdinando D’Amico, Ilaria Faggiani et al. · Journal of Clinical Medicine Open access	30 Jul 2023	49

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.